Oral collagen's measured benefit for skin disappears once pharmaceutical-company-funded and low-quality trials are separated from the rest.
Clinically proven to rebuild collagen from within — visibly firmer, plumper, more hydrated skin in eight weeks.
The market's own words. No brand is named, because the claim is the thing under examination and it belongs to dozens of them.
In adults with visible skin ageing, does daily oral hydrolysed collagen, compared with placebo, improve instrument-measured skin hydration, elasticity and wrinkle depth over eight to twelve weeks — in trials nobody selling collagen paid for?
The same claim written as a proposition somebody could go and check: who, compared with what, measured how, over how long.
What kind of missing this is
The evidence pointing the claimed way was produced or paid for by the people selling the thing. Sometimes that means an in-house study nobody outside the company can read. Sometimes it means published trials whose effect disappears the moment the independently funded ones are read on their own. Industry money does not make a study wrong. It does mean it is not the same evidence as a study nobody paid for.
Myung and Park, in the American Journal of Medicine in September 2025, pooled 23 randomised controlled trials covering 1,474 people. That is a substantial evidence base — larger than almost anything else in this register — and the headline result is a win. Across all 23 trials, collagen supplements significantly improved skin hydration, elasticity and wrinkles.
Then the authors did the thing almost nobody writing about this does, and split the trials by who paid for them.
In the studies not funded by pharmaceutical companies, there was no effect on hydration, no effect on elasticity and no effect on wrinkles. In the studies that were funded by pharmaceutical companies, the effect was significant. The same split appears again when the trials are sorted by quality rather than by money: the high-quality studies showed no significant effect in any category, while the low-quality ones showed an improvement in elasticity and nothing else.
Their conclusion runs to one sentence and it is not hedged. There is currently no clinical evidence to support the use of collagen supplements to prevent or treat skin aging.
Industry funding does not make a study false, and that is worth saying plainly, because the cynical reading is not the one the data supports. What the stratification shows is narrower and more useful than a conspiracy: the positive signal in this literature is not scattered at random. It sits with the trials that had a commercial reason to find it, and it is absent from the ones that did not.
A randomised, placebo-controlled trial running at least twelve weeks in at least 150 adults, funded by somebody with nothing to sell — a research council, a university, a foundation — measuring elasticity and wrinkle depth by instrument rather than by investigator eye or participant questionnaire, and registered before the first person is enrolled.
That is not a demanding bar. It is roughly what the industry-funded trials already do, minus the industry. Pre-registration is named specifically because it is the cheapest protection there is against the outcome being chosen after the numbers come in, and its absence is one of the things separating the low-quality trials in this meta-analysis from the high-quality ones.
One trial of that shape reporting a clear positive moves this entry to Thinly supported. Two move it further.
It does not mean collagen supplements are unsafe. They are hydrolysed protein, and the safety record in this literature is unremarkable.
It does not mean the people who feel better on them are imagining it or lying. Skin hydration answers to a great many things, including drinking more water because you are now in the habit of swallowing something with a full glass every morning, and including the ordinary seasonal swing that makes any before-and-after photographed in different months look like a result.
It does not mean protein is irrelevant to skin. It means that taking protein in this particular form, at these doses, has not been shown to do more for your face than the protein already in your dinner.
And it does not mean the 23 trials were wasted. They are the reason this entry can say something specific rather than shrug.
You are paying for hydrolysed protein powder, usually flavoured, usually priced several times what the same quantity of protein costs in any other form. That part is real and nobody disputes it.
What you are not paying for is a demonstrated effect on your skin. The independently funded trials do not show one.
The honest version of the pitch is a pleasant morning ritual with a plausible mechanism, no proof, and a price borrowed from treatments that have some. If the ritual is what you want, it costs whatever the powder costs and I am not going to be sniffy about it. If the outcome is what you want, the evidence that would justify the price is not there yet — and the boring answer, which is also the correct one, is that the same monthly spend on a sunscreen you actually enjoy wearing has decades of evidence behind it for the exact thing collagen is sold to fix.
Type and funding are stated because they change what a study is allowed to prove, and because a trial paid for by the company selling the thing is not disqualified — it is just not the same evidence as one that was not.